Swiss National Bank

Bank

Position in BHVN — Biohaven Ltd.

CIK 1582202 ZURICH, V8

Position in BHVN

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$3,705,120

+$1,517,364 QoQ

Shares Held

249,000

-3.7% QoQ

Ownership

0.165%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#69

of 294 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Swiss National Bank holds $1,800,323,370 across 152 Biotechnology names. BHVN ranks #75 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	717,440	$356,373,971
2	REGN	Regeneron Pharmaceuticals, Inc.	293,020	$182,709,690
3	ALNY	Alnylam Pharmaceuticals, Inc.	374,080	$112,609,302
4	RVMD	Revolution Medicines, Inc.	456,331	$85,461,669
5	RPRX	Royalty Pharma plc	1,159,800	$65,029,986
6	INSM	INSMED Inc	593,512	$63,280,249
7	INCY	Incyte Corp	476,874	$54,058,436
8	MRNA	Moderna, Inc.	679,900	$47,613,397

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,705,120	249,000	-3.7%	Shares	Sole	2026-08-11
2026-03-31	$2,187,756	258,600	+12.8%	Shares	Sole	2026-05-07
2025-12-31	$2,587,668	229,200	+36.2%	Shares	Sole	2026-02-12
2025-09-30	$2,526,183	168,300	+1.1%	Shares	Sole	2025-11-13
2025-06-30	$2,349,315	166,500	0.0%	Shares	Sole	2025-08-12
2025-03-31	$4,002,660	166,500	+7.6%	Shares	Sole	2025-05-12
2024-12-31	$5,781,780	154,800	+12.2%	Shares	Sole	2025-02-10
2024-09-30	$6,895,860	138,000	-4.6%	Shares	Sole	2024-11-07
2024-06-30	$5,019,066	144,600	+1.5%	Shares	Sole	2024-08-08
2024-03-31	$7,793,325	142,500	+6.3%	Shares	Sole	2024-05-07
2023-12-31	$5,739,480	134,100	+5.2%	Shares	Sole	2024-02-06
2023-09-30	$3,316,275	127,500	+1.0%	Shares	Sole	2023-11-08
2023-06-30	$3,018,704	126,200	-4.7%	Shares	Sole	2023-08-09
2023-03-31	$1,808,584	132,400	—	Shares	Sole	2023-05-10
No filing history on record for this holder in this stock.